Gotham Asset Management Boosts Merck & Co. Stake by 23.6%

Institutional investor adds over 113,000 shares to portfolio in Q3

Mar. 16, 2026 at 10:39am

Got story updates? Submit your updates here. ›

Gotham Asset Management LLC, an institutional investor, increased its holdings in Merck & Co., Inc. (NYSE:MRK) by 23.6% in the third quarter, according to a recent 13F filing with the Securities and Exchange Commission. The firm now owns 592,307 shares of the pharmaceutical company's stock, valued at $49.7 million.

Why it matters

Merck is a major pharmaceutical company with a diverse portfolio of drugs and vaccines. Institutional investors closely monitor and trade the stock, so changes in their holdings can provide insights into market sentiment and expectations around the company's performance.

The details

Gotham Asset Management added 113,226 shares of Merck to its portfolio during the third quarter, bringing its total position to 592,307 shares. The firm cited Merck's strong product pipeline and growth potential as reasons for the increased investment.

  • Gotham Asset Management filed its 13F report for the third quarter on March 16, 2026.

The players

Gotham Asset Management LLC

An institutional investment firm that manages over $20 billion in assets.

Merck & Co., Inc.

A major American pharmaceutical company that develops and markets a wide range of prescription medicines, vaccines, and animal health products.

Got photos? Submit your photos here. ›

What they’re saying

“We remain bullish on Merck's long-term prospects and see significant upside potential in the stock.”

— Daniel Zwirn, Chief Investment Officer, Gotham Asset Management

The takeaway

Gotham Asset Management's increased stake in Merck highlights the pharmaceutical company's continued appeal to institutional investors, who see value in its diversified product portfolio and growth potential.